Latest News Archive
Please select Category, Year, and then Month to display items
08 November 2024
|
Story Jacky Tshokwe
|
Photo Supplied
The Kingdom Vision Foundation (KVF) management team took part in the annual Social Impact Innovation Awards organised by the SAB Foundation.
In September, the Kingdom Vision Foundation (KVF) management team took part in the annual Social Impact Innovation Awards, organised by the SAB Foundation. This competition included a three-day workshop, during which participants received mentorship on enhancing their business models to maximise sustainable impact. Participants also crafted a four-minute business pitch, which they delivered to a panel of independent judges from sectors such as business, health, education, and government. At the end of the workshop, winners were chosen based on the impact of their innovation, the strength of their business model, and the likelihood of future success.
On 10 October, the management team attended the Innovation Awards Ceremony, where KVF was honoured with the Development Award worth R700 000. In addition to the grant, KVF will participate in a 15-month business coaching and mentorship programme in 2025, through which the SAB Foundation’s coaching team will support them in expanding and scaling their impact across South Africa.
The funding will enhance both the Kovsie Health and Anchor of Hope eye clinics, which are collaborating with the University of the Free State (UFS) Department of Optometry to provide affordable eye care to thousands of students and community members. The project aims to improve the quality of education for Optometry students, helping them experience the positive change they can drive through social impact. KVF’s vision includes a future at Kovsie Health where every student’s visual needs are met, regardless of financial constraints, and a thriving Anchor of Hope clinic that brings the gift of sight and renewed hope to rural communities around Bloemfontein.
UFS Chemistry wins dti award
2010-11-02
 |
|
At the awards ceremony are, from the left: Director-General of Trade and Industry Mr Tshediso Matona, Prof. Andreas Roodt and the Deputy-Minister of Trade and Industry, Ms Bongi Maria Ntuli.
Photo: S Osman
|
The research group of Prof. Andreas Roodt, Head of the Department of Chemistry at the University of the Free State (UFS) in Bloemfontein, won the first prize in the category Development of Small Medium and Micro-Enterprises (SMME) at the annual Department of Trade and Industry’s (dti) award ceremony.
Prof. Roodt received the prize for the high-technology project Development of novel nuclear pharmaceuticals in the Technology and Human Resources for Industry Programme (THRIP).
The Deputy-Minister of Trade and Industry Bongi Maria Ntuli, and Director-General Tshediso Matona presented the prize at the gala dinner held at Gallagher Estate, Gauteng in October 2010.
The dti’s Annual Technology Awards recognise excellence in research and aim to raise awareness on the benefits of using technology to improve the competitiveness of enterprises, within the local and global arena. Individuals and organisations are recognised for their efforts in advancing and promoting technology interests and emerging enterprises.
The technology awards cover the achievements of three of the dti technology programmes collectively, namely THRIP, managed by the National Research Foundation (NRF); the Support Programme for Industrial Innovation (SPII) managed by the Industrial Development Corporation (IDC); and the Small Enterprise Development Agency (seda) Technology Programme (stp).
Prof. Roodt, also vice-president of the European Crystallographic Association, who has just returned from a series of lectures abroad after being elected Fellow of the Royal Society of Chemistry in the UK, has received funding in excess of R3 million over the past two years to set up a specialised laboratory for synthesising active compounds. Key partners in this project are Dr Gerdus Kemp from PETLabs Pharmaceuticals in Pretoria; Prof. Connie Medlen (pharmacologist), recently appointed affiliate professor at UFS Chemistry; as well as Prof. Deon Visser from the Inorganic Chemistry research group at the UFS.
The research aims to produce new nuclear medicinal agents for the early diagnosis of cancer, heart and brain defects, and even HIV/ Aids.
Two doctoral students, Alice Brink and Marietjie Schutte, are currently actively involved in this project. They are the recipients of prestige scholarships introduced by the UFS Rector and Vice-Chancellor, Prof. Jonathan Jansen, under the UFS Research Initiative (the Advanced Biomolecular Systems Cluster) to complete their Ph.D. studies.
Media Release
Issued by: Lacea Loader
Director: Strategic Communication (actg)
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl@ufs.ac.za
2 November 2010